ATE374209T1 - Mycobacterium stämme mit einem modifizierten erp gen und enthaltende impfstoffzusammensetzung - Google Patents

Mycobacterium stämme mit einem modifizierten erp gen und enthaltende impfstoffzusammensetzung

Info

Publication number
ATE374209T1
ATE374209T1 AT98940318T AT98940318T ATE374209T1 AT E374209 T1 ATE374209 T1 AT E374209T1 AT 98940318 T AT98940318 T AT 98940318T AT 98940318 T AT98940318 T AT 98940318T AT E374209 T1 ATE374209 T1 AT E374209T1
Authority
AT
Austria
Prior art keywords
composition containing
vaccine composition
mycobacterium strains
erp gene
modified
Prior art date
Application number
AT98940318T
Other languages
English (en)
Inventor
Brigitte Gicquel
Francois-Xavier Berthet
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE374209T1 publication Critical patent/ATE374209T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98940318T 1997-07-22 1998-07-22 Mycobacterium stämme mit einem modifizierten erp gen und enthaltende impfstoffzusammensetzung ATE374209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709303A FR2766495B1 (fr) 1997-07-22 1997-07-22 Souche de mycobacterium dont le gene erp est modifie et composition vaccinale la contenant

Publications (1)

Publication Number Publication Date
ATE374209T1 true ATE374209T1 (de) 2007-10-15

Family

ID=9509488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940318T ATE374209T1 (de) 1997-07-22 1998-07-22 Mycobacterium stämme mit einem modifizierten erp gen und enthaltende impfstoffzusammensetzung

Country Status (8)

Country Link
US (3) US6585976B1 (de)
EP (1) EP0991663B1 (de)
AT (1) ATE374209T1 (de)
AU (1) AU8867198A (de)
CA (1) CA2298063A1 (de)
DE (1) DE69838480D1 (de)
FR (1) FR2766495B1 (de)
WO (1) WO1999005168A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064861A1 (en) 2000-01-11 2002-05-30 Barletta Raul G. Identification of virulence determinants
CA2684923C (en) 2007-05-02 2015-01-06 Merial Limited Dna plasmids having improved expression and stability
MX2010000427A (es) * 2007-07-12 2010-08-18 Univ Washington State Mutagenesis de intercambio alelico en map.
CN102317303A (zh) * 2007-07-31 2012-01-11 约翰·霍普金斯大学 用于肿瘤或感染性疾病的免疫预防或免疫治疗的多肽-核酸偶联物
US10156025B2 (en) 2015-05-04 2018-12-18 University Of South Carolina Monolithic heterogeneous single crystals with multiple regimes for solid state laser applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724183B1 (fr) 1994-09-02 1997-04-11 Pasteur Institut Vecteurs de criblage et/ou d'expression fonctionnels chez les mycobacteries - utilisation pour l'identification et l'expression de polypeptides exportes
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein

Also Published As

Publication number Publication date
US6585976B1 (en) 2003-07-01
US20060115497A1 (en) 2006-06-01
FR2766495A1 (fr) 1999-01-29
FR2766495B1 (fr) 2001-07-13
CA2298063A1 (fr) 1999-02-04
US20030091597A1 (en) 2003-05-15
EP0991663B1 (de) 2007-09-26
WO1999005168A1 (fr) 1999-02-04
AU8867198A (en) 1999-02-16
US7597896B2 (en) 2009-10-06
EP0991663A1 (de) 2000-04-12
US7160548B2 (en) 2007-01-09
DE69838480D1 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
HUP9802554A2 (hu) Bevonattal részben ellátott kormot tartalmazó elasztomer kompoundok
AU1083992A (en) Formulations of d-cycloserine as cognitive enhancers
EP0281239A3 (en) Prostaglandins of the d series, and tranquilizers and soporifics containing the same
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
HUP9702307A2 (hu) Antigén kibocsátásra alkalmas készítmény
TR199901961T2 (xx) Amoksosilin ve klav�lanat i�eren ispen�iyariler.
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
FI952797A0 (fi) D-vitamiinianalogin uusi kiteinen muoto
HUP9702301A2 (hu) Térhálósítható elasztomer kompozíciók és eljárás térhálósítható elasztomer kompozíciók előállítására
ATE374209T1 (de) Mycobacterium stämme mit einem modifizierten erp gen und enthaltende impfstoffzusammensetzung
TW282489B (de)
NZ513130A (en) Vaccine composition containing a monoglyceride adjuvant with inactivated Mycobacterium tuberculosis bacteria
FI922932A0 (fi) Ytmodifierade flingformiga substrat med foerbaettrade saettnings- och aoterdispergeringsegenskaper.
NO180642C (no) Alkalipullulanase og renisolert kultur av Bacillus sp. mikroorganisme som produserer denne
PT86034A (de) Klonierung und verwendung des transminase-gens ilve
TR199901862T2 (xx) Yeni Bile�ikler.
DE68913128D1 (de) Verfahren zur Herstellung von L-Alanin-Dehydrogenase und Mikroorganismusstamm des Genus Sporolactobacillus.
GR3004866T3 (de)
TR25367A (tr) Payplaynlarin veya pasajlarin astarlanmasi ile ilgili islahat
IE821944L (en) Fluorinated diamino-heptene and -heptyne derivatives
ES2090312T3 (es) Segmentos de adn y microorganismos transformados que comprenden el gen de la delta-1-deshidrogenasa, y sus aplicaciones.
RO94553B (ro) Compozitie insecticida
FR2599371B1 (fr) Copolymerisation de dichlorosilanes avec des bis(chlorosilyl)-methanes, les produits obtenus et les utilisations desdits produits
DE3879440D1 (de) Dactylocyclin a und dactylocyclin b.
IT1264446B1 (it) Acido 3 (n-(2-mercapto-propionil-ammino-acetil))-tetraidrotiazolil-4- carbossilico come agente antiinfiammatorio e immunostimolante

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties